Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (191-200 of 272) with videos related to

Pageof 28
Sort By:
European Urology Focus|July 30, 2017
Selection Effects May Explain Smoking-related Outcome Differences After Radical CystectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
British Journal of Pharmacology|May 10, 2005
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contractionMelinda Wuest, Juliane Hecht, Torsten Christ, et al.
BMC Urology|October 24, 2018
Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
Diagnostics (Basel, Switzerland)|August 14, 2020
Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate CancerAngelika Borkowetz, Andrea Lohse-Fischer, Jana Scholze, et al.
Plos One|July 16, 2014
Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinomaMarieta I Toma, Kati Erdmann, Michael Diezel, et al.
Scandinavian Journal of Urology and Nephrology|November 24, 2005
Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Urologia Internationalis|October 23, 2019
Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical CystectomyMichael Froehner, David Muallah, Rainer Koch, et al.
Journal of Biomedical Nanotechnology|April 16, 2014
Carbon nanofibers and carbon nanotubes sensitize prostate and bladder cancer cells to platinum-based chemotherapeuticsJessica Ringel, Kati Erdmann, Silke Hampel, et al.
The Journal of Urology|June 11, 2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause, Yvonne Förster, Kai Kraemer, et al.
European Journal of Cancer Care|December 21, 2018
Online support groups offer low-threshold backing for family and friends of patients with prostate cancerAndreas Ihrig, Theresa Renner, Tanja Muck, et al.
Pageof 28

Showing results (191-200 of 272) with videos related to

Sort By:
Pageof 28
European Urology Focus|July 30, 2017
Selection Effects May Explain Smoking-related Outcome Differences After Radical CystectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
British Journal of Pharmacology|May 10, 2005
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contractionMelinda Wuest, Juliane Hecht, Torsten Christ, et al.
BMC Urology|October 24, 2018
Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
Diagnostics (Basel, Switzerland)|August 14, 2020
Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate CancerAngelika Borkowetz, Andrea Lohse-Fischer, Jana Scholze, et al.
Plos One|July 16, 2014
Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinomaMarieta I Toma, Kati Erdmann, Michael Diezel, et al.
Scandinavian Journal of Urology and Nephrology|November 24, 2005
Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Urologia Internationalis|October 23, 2019
Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical CystectomyMichael Froehner, David Muallah, Rainer Koch, et al.
Journal of Biomedical Nanotechnology|April 16, 2014
Carbon nanofibers and carbon nanotubes sensitize prostate and bladder cancer cells to platinum-based chemotherapeuticsJessica Ringel, Kati Erdmann, Silke Hampel, et al.
The Journal of Urology|June 11, 2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause, Yvonne Förster, Kai Kraemer, et al.
European Journal of Cancer Care|December 21, 2018
Online support groups offer low-threshold backing for family and friends of patients with prostate cancerAndreas Ihrig, Theresa Renner, Tanja Muck, et al.
Pageof 28